SCHEMBL239938

SCHEMBL239938

NC(c1ccccc1)C(N)c1ccccc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 2/20 1.00
F2 P00734 1/20 0.65
HTR2A P28223 1/20 0.50
TAAR1 Q96RJ0 1/20 0.50
ADRA2A P08913 1/20 0.48
ADRA2C P18825 1/20 0.48
LMNA P02545 1/20 0.48
HIF1A Q16665 1/20 0.48
KDM4E B2RXH2 1/20 0.48
TSHR P16473 1/20 0.47
ALDH1A1 P00352 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1878642 1.00 DPP4 (1.00) DPP4F2HTR2ATAAR1ADRA2A
SCHEMBL2067094 1.00 DPP4 (1.00) DPP4F2HTR2ATAAR1ADRA2A
SCHEMBL644767 1.00 DPP4 (1.00) DPP4F2HTR2ATAAR1ADRA2A
SCHEMBL851654 1.00 DPP4 (1.00) DPP4F2HTR2ATAAR1ADRA2A
SCHEMBL150159 1.00 DPP4 (1.00) DPP4F2HTR2ATAAR1ADRA2A
Ammonia Solution, Strong SCHEMBL4410348 0.97 DPP4 (0.93) DPP4F2HTR2ATAAR1ADRA2A
Hydrochloric Acid SCHEMBL9670481 0.97 DPP4 (0.93) DPP4F2HTR2ATAAR1ADRA2A
Lithium SCHEMBL31260781 0.97 DPP4 (0.93) DPP4F2HTR2ATAAR1ADRA2A
SCHEMBL10350027 0.97 DPP4 (0.93) DPP4F2HTR2ATAAR1ADRA2A
SCHEMBL6743969 0.97 DPP4 (0.93) DPP4F2HTR2ATAAR1ADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1802 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122036529-A Preparation method of enantiomerically enriched amino alcohol compound 苏州亚科科技股份有限公司 2026-05-15 CN claimed
CN-122010940-A Citric acid-based fluorescent dye with long-life characteristic of water, and preparation method and application thereof 西湖大学 2026-05-12 CN claimed
US-12460155-B2 Sugar/gluconoamide alkoxylate compositions and uses thereof ECOLAB USA INC. (US) 2025-11-04 US claimed
US-12441700-B2 Hydrogenation of imines with RU complexes FIRMENICHI SA (CH) 2025-10-14 US claimed
EP-4628491-A1 SYNTHESIS OF INTERMEDIATES FOR THE PREPARATION OF NEUROKININ-3 RECEPTOR ANTAGONISTS Química Sintética, S.A. (ES) 2025-10-08 EP claimed
CN-112898210-B Process for preparing pyrimidinylcyclopentane compounds 豪夫迈·罗氏有限公司 2025-02-21 CN claimed
CN-119351771-A Method for improving copper recovery rate through copper-containing dangerous waste copper regeneration smelting 江西省金瑞环保科技有限公司 2025-01-24 CN claimed
CN-115505278-B Recycled plant composite fiber and preparation method thereof 陆进貌 2024-09-27 CN claimed
CN-115403718-B Surface molecular imprinting fluorescence sensor based on aggregation-induced emission group, preparation method and application thereof in rhodamine 6G detection 河南工业大学 2024-08-13 CN claimed
CN-118439986-A Chiral binuclear thiourea organic catalyst and preparation method and application thereof 苏州源锂新材料科技有限公司 2024-08-06 CN claimed
US-5378635-A Method of measuring a catecholamine and its metabolite HITACHI, LTD. (JP) 1995-01-03 US claimed
US-5308774-A Deproteinization, transferring and desorption HITACHI, LTD. (JP) 1994-05-03 US claimed
US-5112704-A NON-AQUEOUS ELECTROLYTE CELL SANYO ELECTRIC CO., LTD. (JP) 1992-05-12 US claimed
US-5093267-A Chromatography, converting component to detectable derivative HITACHI, LTD. (JP) 1992-03-03 US claimed
EP-0193055-B1 ANTITUMORALS(1,2-DIPHENYL-ETHYLENE DIAMINE)-PLATINUM (II) COMPLEXES ASTA Pharma AG (DE) 1990-05-16 EP claimed
EP-0349675-A2 Non-aqueous electrolyte cell SANYO ELECTRIC CO., LTD. (JP) 1990-01-10 EP claimed
US-4705757-A Method for fluorometric analysis of catechol amines TOYO SODA MANUFACTURING CO., LTD. (JP) 1987-11-10 US claimed
US-4477387-A ANTILTUMOR AGENTS OTSUKA CHEMICAL CO., LTD. (JP) 1984-10-16 US claimed
EP-0085023-A1 Process for the separation of enantiomers by partition between liquid phases CIBA-GEIGY AG (CH) 1983-08-03 EP claimed
EP-0055300-A1 PLATINUM (II) COMPLEXES AND ANTINEOPLASTIC AGENTS CONTAINING SAME AS EFFECTIVE INGREDIENTS OTSUKA CHEMICAL COMPANY, LIMITED (JP) 1982-07-07 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12441700-B2 Hydrogenation of imines with RU complexes HRH3, HNMT, HRH4 DPP4 4188/4885F2 843/4885HTR2A 892/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.